Concepts (203)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Protein Phosphatase 1 | 11 | 2024 | 62 | 2.330 |
Why?
|
| Virus Replication | 11 | 2024 | 278 | 1.650 |
Why?
|
| HIV-1 | 9 | 2022 | 706 | 1.190 |
Why?
|
| Ebolavirus | 4 | 2019 | 42 | 1.080 |
Why?
|
| Transcription, Genetic | 8 | 2022 | 578 | 0.960 |
Why?
|
| Cyclin-Dependent Kinase 9 | 4 | 2018 | 37 | 0.900 |
Why?
|
| Antiviral Agents | 3 | 2018 | 157 | 0.740 |
Why?
|
| Phosphorylation | 12 | 2024 | 928 | 0.570 |
Why?
|
| Serine | 3 | 2018 | 75 | 0.560 |
Why?
|
| Polycythemia | 5 | 2017 | 15 | 0.530 |
Why?
|
| Anti-HIV Agents | 3 | 2015 | 420 | 0.480 |
Why?
|
| Anemia, Sickle Cell | 4 | 2021 | 183 | 0.470 |
Why?
|
| RNA-Binding Proteins | 3 | 2012 | 146 | 0.450 |
Why?
|
| Gene Expression Regulation, Viral | 4 | 2019 | 110 | 0.450 |
Why?
|
| Biocatalysis | 1 | 2012 | 28 | 0.420 |
Why?
|
| Viral Proteins | 6 | 2024 | 174 | 0.420 |
Why?
|
| Small Molecule Libraries | 1 | 2012 | 45 | 0.410 |
Why?
|
| Rift Valley fever virus | 2 | 2024 | 8 | 0.380 |
Why?
|
| Endoribonucleases | 1 | 2010 | 23 | 0.370 |
Why?
|
| Phosphoprotein Phosphatases | 1 | 2010 | 46 | 0.370 |
Why?
|
| RNA, Viral | 7 | 2024 | 301 | 0.360 |
Why?
|
| tat Gene Products, Human Immunodeficiency Virus | 3 | 2018 | 53 | 0.340 |
Why?
|
| Von Hippel-Lindau Tumor Suppressor Protein | 5 | 2017 | 18 | 0.330 |
Why?
|
| Erythropoietin | 4 | 2016 | 39 | 0.270 |
Why?
|
| Cell Line | 6 | 2024 | 1354 | 0.270 |
Why?
|
| Vero Cells | 6 | 2024 | 93 | 0.250 |
Why?
|
| Transcription Factors | 3 | 2019 | 681 | 0.230 |
Why?
|
| Hydroxyurea | 2 | 2016 | 34 | 0.230 |
Why?
|
| Humans | 25 | 2024 | 37093 | 0.220 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 3 | 2012 | 187 | 0.200 |
Why?
|
| Sickle Cell Trait | 1 | 2021 | 17 | 0.200 |
Why?
|
| Amino Acid Sequence | 3 | 2018 | 1180 | 0.200 |
Why?
|
| Drug Stability | 2 | 2018 | 116 | 0.190 |
Why?
|
| Animals | 10 | 2024 | 15081 | 0.180 |
Why?
|
| Catalytic Domain | 2 | 2018 | 109 | 0.180 |
Why?
|
| Protein Binding | 5 | 2018 | 972 | 0.180 |
Why?
|
| Urea | 2 | 2019 | 41 | 0.180 |
Why?
|
| Viral Core Proteins | 1 | 2019 | 10 | 0.180 |
Why?
|
| Nucleoproteins | 1 | 2019 | 11 | 0.180 |
Why?
|
| Lymphopenia | 1 | 2019 | 16 | 0.170 |
Why?
|
| Mass Spectrometry | 2 | 2011 | 260 | 0.170 |
Why?
|
| Hemorrhagic Fever, Ebola | 1 | 2019 | 29 | 0.170 |
Why?
|
| Encephalitis Virus, Venezuelan Equine | 1 | 2018 | 9 | 0.160 |
Why?
|
| Hypoxia-Inducible Factor 1, alpha Subunit | 3 | 2017 | 84 | 0.160 |
Why?
|
| Indoles | 2 | 2019 | 158 | 0.160 |
Why?
|
| Molecular Sequence Data | 2 | 2012 | 1568 | 0.160 |
Why?
|
| Capsid | 1 | 2018 | 54 | 0.160 |
Why?
|
| Capsid Proteins | 1 | 2018 | 67 | 0.150 |
Why?
|
| CD4-Positive T-Lymphocytes | 1 | 2019 | 259 | 0.150 |
Why?
|
| Cyclin-Dependent Kinase 2 | 2 | 2018 | 31 | 0.150 |
Why?
|
| Cytochrome-B(5) Reductase | 1 | 2017 | 3 | 0.150 |
Why?
|
| Methemoglobinemia | 1 | 2017 | 2 | 0.150 |
Why?
|
| Cyclic AMP-Dependent Protein Kinase RIalpha Subunit | 1 | 2016 | 2 | 0.140 |
Why?
|
| Thrombospondin 1 | 1 | 2017 | 23 | 0.140 |
Why?
|
| Thrombosis | 1 | 2017 | 63 | 0.140 |
Why?
|
| HIV Infections | 2 | 2021 | 2303 | 0.140 |
Why?
|
| Cells, Cultured | 3 | 2018 | 1518 | 0.130 |
Why?
|
| Germ-Line Mutation | 2 | 2017 | 57 | 0.130 |
Why?
|
| Models, Molecular | 3 | 2018 | 808 | 0.130 |
Why?
|
| T-Lymphocytes | 2 | 2015 | 357 | 0.130 |
Why?
|
| Homozygote | 3 | 2013 | 77 | 0.130 |
Why?
|
| Reverse Transcriptase Inhibitors | 1 | 2015 | 57 | 0.130 |
Why?
|
| Basic Helix-Loop-Helix Transcription Factors | 2 | 2013 | 80 | 0.130 |
Why?
|
| Leukocytes, Mononuclear | 4 | 2021 | 234 | 0.130 |
Why?
|
| DNA Replication | 1 | 2016 | 152 | 0.130 |
Why?
|
| Curcumin | 1 | 2015 | 74 | 0.120 |
Why?
|
| Antisickling Agents | 2 | 2016 | 15 | 0.120 |
Why?
|
| Mitogen-Activated Protein Kinase 8 | 1 | 2014 | 12 | 0.120 |
Why?
|
| Streptomycin | 1 | 2013 | 4 | 0.120 |
Why?
|
| Mice | 3 | 2022 | 5913 | 0.120 |
Why?
|
| Mutation | 3 | 2018 | 1095 | 0.120 |
Why?
|
| Phosphotransferases (Alcohol Group Acceptor) | 1 | 2013 | 31 | 0.120 |
Why?
|
| Gene Expression Regulation | 2 | 2016 | 1015 | 0.120 |
Why?
|
| Anemia, Iron-Deficiency | 1 | 2013 | 18 | 0.110 |
Why?
|
| Gene Expression | 1 | 2017 | 674 | 0.110 |
Why?
|
| Enzyme Activation | 2 | 2012 | 444 | 0.110 |
Why?
|
| Hypertension, Pulmonary | 1 | 2014 | 75 | 0.110 |
Why?
|
| Nuclear Proteins | 2 | 2012 | 307 | 0.110 |
Why?
|
| Intracellular Space | 1 | 2012 | 35 | 0.110 |
Why?
|
| Amino Acid Motifs | 1 | 2012 | 91 | 0.100 |
Why?
|
| Polymorphism, Single Nucleotide | 1 | 2016 | 767 | 0.100 |
Why?
|
| Host-Pathogen Interactions | 3 | 2019 | 186 | 0.100 |
Why?
|
| DNA-Binding Proteins | 2 | 2012 | 539 | 0.100 |
Why?
|
| Iron | 1 | 2013 | 225 | 0.100 |
Why?
|
| Peptide Mapping | 1 | 2011 | 19 | 0.100 |
Why?
|
| Protein Transport | 1 | 2012 | 302 | 0.100 |
Why?
|
| Antimicrobial Cationic Peptides | 1 | 2011 | 35 | 0.100 |
Why?
|
| Point Mutation | 2 | 2009 | 93 | 0.100 |
Why?
|
| Threonine | 1 | 2010 | 25 | 0.090 |
Why?
|
| Electrophoresis, Polyacrylamide Gel | 1 | 2011 | 201 | 0.090 |
Why?
|
| Gene Products, tat | 1 | 2010 | 35 | 0.090 |
Why?
|
| Rift Valley Fever | 2 | 2024 | 7 | 0.090 |
Why?
|
| RNA Polymerase II | 1 | 2010 | 29 | 0.090 |
Why?
|
| Binding Sites | 1 | 2012 | 651 | 0.090 |
Why?
|
| Anti-Bacterial Agents | 1 | 2013 | 352 | 0.090 |
Why?
|
| Cell Nucleus | 1 | 2012 | 366 | 0.090 |
Why?
|
| Rabbits | 1 | 2010 | 283 | 0.090 |
Why?
|
| Genome, Viral | 2 | 2024 | 109 | 0.090 |
Why?
|
| Fetal Hemoglobin | 1 | 2009 | 14 | 0.090 |
Why?
|
| Tricuspid Valve Insufficiency | 1 | 2009 | 12 | 0.090 |
Why?
|
| Peptides | 1 | 2012 | 320 | 0.090 |
Why?
|
| Bacterial Proteins | 1 | 2013 | 540 | 0.080 |
Why?
|
| CDC2 Protein Kinase | 1 | 2008 | 17 | 0.080 |
Why?
|
| RNA Splicing | 1 | 2008 | 40 | 0.080 |
Why?
|
| RNA, Messenger | 2 | 2014 | 1207 | 0.080 |
Why?
|
| Genetic Diseases, Inborn | 1 | 2008 | 12 | 0.080 |
Why?
|
| Homocysteine | 1 | 2008 | 19 | 0.080 |
Why?
|
| Dipeptides | 1 | 2008 | 32 | 0.080 |
Why?
|
| Glutathione | 1 | 2008 | 179 | 0.070 |
Why?
|
| Female | 9 | 2021 | 20969 | 0.070 |
Why?
|
| RNA, Small Interfering | 2 | 2019 | 409 | 0.070 |
Why?
|
| RNA Interference | 2 | 2019 | 243 | 0.060 |
Why?
|
| Cytokines | 1 | 2009 | 602 | 0.060 |
Why?
|
| Casein Kinase Ialpha | 1 | 2024 | 2 | 0.060 |
Why?
|
| Protein Conformation | 2 | 2018 | 389 | 0.060 |
Why?
|
| Male | 8 | 2017 | 20025 | 0.060 |
Why?
|
| PPAR alpha | 1 | 2022 | 42 | 0.050 |
Why?
|
| Cell Hypoxia | 2 | 2014 | 58 | 0.050 |
Why?
|
| Transforming Growth Factor beta | 1 | 2022 | 197 | 0.050 |
Why?
|
| Case-Control Studies | 2 | 2017 | 1130 | 0.050 |
Why?
|
| Russia | 2 | 2011 | 25 | 0.050 |
Why?
|
| Adult | 5 | 2017 | 11712 | 0.040 |
Why?
|
| Nucleocapsid Proteins | 1 | 2019 | 9 | 0.040 |
Why?
|
| Child | 3 | 2017 | 3131 | 0.040 |
Why?
|
| Jurkat Cells | 1 | 2019 | 79 | 0.040 |
Why?
|
| Ribonucleoproteins | 1 | 2019 | 29 | 0.040 |
Why?
|
| Antigens, Viral | 1 | 2019 | 43 | 0.040 |
Why?
|
| Viral Matrix Proteins | 1 | 2019 | 17 | 0.040 |
Why?
|
| Chiroptera | 1 | 2019 | 20 | 0.040 |
Why?
|
| Virion | 1 | 2019 | 69 | 0.040 |
Why?
|
| Immunoprecipitation | 2 | 2010 | 131 | 0.040 |
Why?
|
| Child, Preschool | 2 | 2017 | 1418 | 0.040 |
Why?
|
| Viral Envelope Proteins | 1 | 2019 | 82 | 0.040 |
Why?
|
| Cyclin T | 1 | 2018 | 16 | 0.040 |
Why?
|
| Autophagy | 1 | 2019 | 116 | 0.040 |
Why?
|
| eIF-2 Kinase | 1 | 2018 | 14 | 0.040 |
Why?
|
| Hela Cells | 2 | 2010 | 366 | 0.040 |
Why?
|
| Ubiquitination | 1 | 2018 | 61 | 0.040 |
Why?
|
| Gene Knockdown Techniques | 1 | 2018 | 173 | 0.040 |
Why?
|
| Methemoglobin | 1 | 2017 | 3 | 0.040 |
Why?
|
| Erythrocyte Count | 1 | 2017 | 11 | 0.040 |
Why?
|
| Siberia | 1 | 2017 | 4 | 0.040 |
Why?
|
| Proteomics | 1 | 2019 | 325 | 0.040 |
Why?
|
| Adolescent | 3 | 2017 | 5363 | 0.040 |
Why?
|
| Alternative Splicing | 1 | 2017 | 85 | 0.040 |
Why?
|
| Hemoglobins | 1 | 2017 | 107 | 0.030 |
Why?
|
| Genetic Association Studies | 1 | 2016 | 114 | 0.030 |
Why?
|
| HIV Reverse Transcriptase | 1 | 2015 | 33 | 0.030 |
Why?
|
| Enzyme Induction | 1 | 2015 | 53 | 0.030 |
Why?
|
| Half-Life | 1 | 2015 | 54 | 0.030 |
Why?
|
| Heme Oxygenase-1 | 1 | 2015 | 51 | 0.030 |
Why?
|
| Proportional Hazards Models | 1 | 2017 | 441 | 0.030 |
Why?
|
| Virulence | 1 | 2016 | 223 | 0.030 |
Why?
|
| Models, Biological | 1 | 2018 | 677 | 0.030 |
Why?
|
| DNA-Directed RNA Polymerases | 1 | 2014 | 22 | 0.030 |
Why?
|
| Middle Aged | 3 | 2017 | 10129 | 0.030 |
Why?
|
| Prognosis | 1 | 2017 | 739 | 0.030 |
Why?
|
| Transfection | 1 | 2015 | 523 | 0.030 |
Why?
|
| Follow-Up Studies | 1 | 2017 | 974 | 0.030 |
Why?
|
| Incidence | 1 | 2017 | 922 | 0.030 |
Why?
|
| Phlebotomy | 1 | 2013 | 5 | 0.030 |
Why?
|
| Streptomyces | 1 | 2013 | 16 | 0.030 |
Why?
|
| Risk Assessment | 1 | 2017 | 753 | 0.030 |
Why?
|
| Quantitative Trait Loci | 1 | 2014 | 77 | 0.030 |
Why?
|
| Protein Stability | 1 | 2013 | 45 | 0.030 |
Why?
|
| Sex Factors | 1 | 2017 | 898 | 0.030 |
Why?
|
| Infant | 1 | 2017 | 1046 | 0.030 |
Why?
|
| Drug Resistance, Bacterial | 1 | 2013 | 77 | 0.030 |
Why?
|
| Gene Expression Regulation, Enzymologic | 1 | 2014 | 168 | 0.030 |
Why?
|
| Microbial Sensitivity Tests | 1 | 2013 | 201 | 0.030 |
Why?
|
| Gene Expression Profiling | 1 | 2016 | 626 | 0.030 |
Why?
|
| Positive Transcriptional Elongation Factor B | 1 | 2012 | 14 | 0.030 |
Why?
|
| Immunity, Innate | 1 | 2013 | 149 | 0.030 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2015 | 1039 | 0.030 |
Why?
|
| Recombinant Proteins | 1 | 2013 | 515 | 0.030 |
Why?
|
| Prevalence | 1 | 2017 | 1455 | 0.030 |
Why?
|
| Kinetics | 1 | 2013 | 708 | 0.030 |
Why?
|
| Gene Silencing | 1 | 2012 | 151 | 0.030 |
Why?
|
| Chromatography, High Pressure Liquid | 1 | 2013 | 421 | 0.020 |
Why?
|
| Insulin | 1 | 2013 | 236 | 0.020 |
Why?
|
| Blood Glucose | 1 | 2013 | 353 | 0.020 |
Why?
|
| Ferritins | 1 | 2011 | 55 | 0.020 |
Why?
|
| Retrospective Studies | 1 | 2017 | 2026 | 0.020 |
Why?
|
| Mutant Proteins | 1 | 2010 | 51 | 0.020 |
Why?
|
| Escherichia coli | 1 | 2013 | 453 | 0.020 |
Why?
|
| Aged, 80 and over | 1 | 2017 | 2379 | 0.020 |
Why?
|
| Cohort Studies | 1 | 2014 | 1492 | 0.020 |
Why?
|
| Prospective Studies | 1 | 2014 | 1378 | 0.020 |
Why?
|
| Protein Structure, Tertiary | 1 | 2010 | 408 | 0.020 |
Why?
|
| Down-Regulation | 1 | 2011 | 435 | 0.020 |
Why?
|
| CD4-CD8 Ratio | 1 | 2009 | 30 | 0.020 |
Why?
|
| Inflammation | 1 | 2014 | 618 | 0.020 |
Why?
|
| Interleukins | 1 | 2009 | 29 | 0.020 |
Why?
|
| Young Adult | 2 | 2009 | 4268 | 0.020 |
Why?
|
| Exons | 1 | 2009 | 88 | 0.020 |
Why?
|
| gamma-Glutamyltransferase | 1 | 2008 | 8 | 0.020 |
Why?
|
| Vascular Endothelial Growth Factor A | 1 | 2009 | 161 | 0.020 |
Why?
|
| Tumor Necrosis Factor-alpha | 1 | 2009 | 356 | 0.020 |
Why?
|
| Genotype | 1 | 2009 | 730 | 0.020 |
Why?
|
| Apoptosis | 1 | 2014 | 1398 | 0.020 |
Why?
|
| Aged | 1 | 2017 | 6741 | 0.020 |
Why?
|
| Signal Transduction | 1 | 2013 | 1908 | 0.020 |
Why?
|
| Blood Pressure | 1 | 2008 | 646 | 0.010 |
Why?
|